TNKASE
TNKASE
Approved
DIN Number
02244826
Drug Class
Human
Market Date
Oct 18, 2001
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02244826
AIG Number0145681001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B01AD11 TENECTEPLASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:12.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
TENECTEPLASEActive
Strength: 50 MG / VIAL
Monograph: TENECTEPLASE